Nebula Research & Development’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-35,414
Closed -$210K 77
2025
Q2
$210K Sell
35,414
-22,402
-39% -$129K 0.02% 884
2025
Q1
$369K Buy
57,816
+11,029
+24% +$106K 0.03% 702
2024
Q4
$556K Buy
46,787
+30,352
+185% +$517K 0.07% 517
2024
Q3
$455K Buy
16,435
+7,819
+91% +$196K 0.05% 581
2024
Q2
$205K Buy
+8,616
New +$202K 0.03% 724
2024
Q1
Sell
-22,039
Closed -$348K 738
2023
Q4
$348K Sell
22,039
-10,690
-33% -$110K 0.1% 387
2023
Q3
$281K Sell
32,729
-13,317
-29% -$94.6K 0.15% 293
2023
Q2
$363K Buy
46,046
+12,412
+37% +$86.4K 0.28% 184
2023
Q1
$251K Buy
+33,634
New +$334K 0.44% 141

Other funds holding ASPN

Nebula Research & Development's ASPN Position: Q3 2025 in Review

Nebula Research & Development sold out of Aspen Aerogels (ASPN) in Q3 2025, closing a stake of 35,414 shares — an estimated $210K sold.

Nebula Research & Development first reported a position in ASPN in Q1 2023 and held it in 9 quarters. The position peaked at $556K in Q4 2024. 204 funds tracked by Wall St. Rank hold ASPN as of Q3 2025.

  • Nebula Research & Development reported no remaining Aspen Aerogels position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 35,414 Aspen Aerogels shares in Q3 2025, an estimated $210K.
  • Nebula Research & Development first reported a position in Aspen Aerogels in Q1 2023 and held it in 9 quarters.
  • Nebula Research & Development's Aspen Aerogels position peaked at $556K in Q4 2024.
  • 204 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.